Richard Caradonna
Medical Oncology · Brooksville, FLNPI 1356301733
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,640 of the $1,910 with a category attached, or 85.8%. It is spread thinly across 26 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,736 and has fallen 98.8% since, to $20 in 2023. That places this record below the midpoint for medical oncology clinicians in FL, where the typical reported total is $8,890.
Across 122 payments — averaging $15.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$239
- Lilly USA, LLC$229
- Genentech USA, Inc.$224
- Merck$198
- Amgen$162
- Novartis$153
- plus $704 from 20 others
Across 27 payments — averaging $2115.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Incyte Corporation$57K
What the payments were for
- Food & beverage$1,64086%
- Education$27114%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 16 | $239 |
| Lilly USA, LLC | 9 | $229 |
| Genentech USA, Inc. | 15 | $224 |
| Merck | 12 | $198 |
| Amgen | 6 | $162 |
| Novartis | 11 | $153 |
| Pfizer | 15 | $123 |
| Bayer | 4 | $68 |
| Daiichi Sankyo Inc. | 4 | $58 |
| Eisai Inc. | 3 | $52 |
| Foundation Medicine, Inc. | 1 | $52 |
| Sanofi | 3 | $48 |
| AstraZeneca | 3 | $38 |
| Ipsen Biopharmaceuticals, Inc | 3 | $35 |
| AbbVie | 2 | $32 |
| E.r. Squibb & Sons, L.L.C. | 2 | $28 |
| Astellas Pharma US Inc | 2 | $25 |
| Teva Pharmaceuticals USA, Inc. | 2 | $24 |
| Clovis Oncology, Inc. | 2 | $22 |
| Partner Therapeutics, Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $15 |
| AMAG Pharmaceuticals, Inc. | 1 | $15 |
| Regeneron Healthcare Solutions, Inc. | 1 | $14 |
| EMD Serono, Inc. | 1 | $14 |
| Incyte Corporation | 1 | $13 |
| Acrotech Biopharma Inc. | 1 | $12 |
How this compares
$1,910 in reported general payments places this provider in the 20th percentile of 507 medical oncology providers in Florida.
Other medical oncology in Brooksville
- Neil LoveMiami$5.6M
- Mahdi TahaBoca Raton$1.7M
- Raji ShameemOrlando$1.3M
- Mohammad JahanzebBoca Raton$1.3M
- Michel VelezOrlando$927K
- Yuanbin ChenOrlando$810K
- Reshma MahtaniPlantation$608K
- Rebecca MorooseOrlando$543K
- Yasser KhaledOrlando$444K
- Judah FriedmanPalm Beach Gardens$416K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.